The Pros and Cons of Delaying Breast Reconstruction Surgery During the COVID-19 Pandemic

Video

There are advantages and disadvantages to delaying elective reconstructive breast surgery, according to one expert.

The development and spread of the novel coronavirus has forced all elective medical procedures to take a backseat to care that is deemed essential — or lifesaving – to keep people from contracting COVID-19.

One of those procedures, reconstructive surgery following breast cancer, has all but come to a screeching halt.

In an interview with CURE®, Dr. Jonathan Bank, a board-certified plastic surgeon at New York Breast Reconstruction and Aesthetic (NYBRA) Plastic Surgery, discussed the pros and cons of delaying breast reconstruction surgery for an unknown period due to COVID-19.

“In terms of the reconstruction, there are pros and cons to doing reconstruction in different time sets,” Bank, who specializes in breast reconstruction after cancer, said. “For instance, in the case of mastectomy or a bilateral mastectomy there are many benefits to performing an immediate reconstruction.”

The advantages of an immediate reconstruction, according to Bank, include preserving the natural skin envelope, the skin remains soft and has its natural shape.

“Psychologically, there’s huge advantage in performing an immediate reconstruction,” he said. “Now, that’s not to say delayed reconstruction is not an option. It's absolutely an option. But you're starting off with a slight disadvantage.”

Although there are advantages to having reconstructive surgery immediately, there are also benefits to waiting and spacing out surgeries in patients who may have already started the reconstruction process before the spread of COVID-19.

“That includes the tissue that was operated on, the skin, the fat underneath the skin, everything goes through a healing sequence that just takes time to calm down,” he said. “Actually, the longer you wait the better off you are in terms of the palette that you are now working on. If you operate too soon, things may still be swollen, they may not be as supple and easily managed surgically.”

Bank assures patients not to worry about having to push off those follow-up reconstructive surgeries. The tissue expanders that may have been originally placed can stay in the body for years, he said.

“It's not the most comfortable thing in the world, it definitely throws a wrench in life planning, but again in a risk-benefit balance, there is no problem to wait just to be safe,” Bank concluded.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE